DOCETAXEL
C5851005
Phase 3 small_molecule active
Quick answer
DOCETAXEL for Non-Small Cell Lung Cancer (NSCLC) is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active